Affordable Access

Publisher Website

Decreased serum osteocalcin levels in patients with liver cirrhosis

Authors
Journal
Bone and Mineral
0169-6009
Publisher
Elsevier
Publication Date
Volume
8
Issue
2
Identifiers
DOI: 10.1016/0169-6009(90)90113-t
Keywords
  • Osteocalcin
  • Bone Gla Protein
  • Liver Cirrhosis
  • Bone Formation
  • Bone Densitometry
Disciplines
  • Chemistry
  • Medicine
  • Physics

Abstract

Abstract Serum levels of osteocalcin (OC) have been found to be a specific biochemical parameter of bone formation. We measured serum levels of osteocalcin, parathyroid hormone (PTH) and 25-hydroxyvitamin D (25(OH)D) in 49 patients with liver cirrhosis, who are known to have an increased prevalence of metabolic bone disease, and a matched control group ( n = 35). Serum levels of OC were significantly decreased in the patients with liver cirrhosis when compared to control subjects ( P < 0.001). Serum levels of 25(OH)D were decreased ( P < 0.001), whereas no statistical difference was found between the serum levels of PTH in the patients with liver cirrhosis and those of the controls. In a subgroup of 23 patients with cirrhosis of the liver and 34 control subjects, the bone mineral content (BMC) of the non-dominant forearm was determined by single photon absorptiometry. BMC was significantly lower in the patient with liver cirrhosis than the control subjects ( P < 0.04). Our data demonstrate vitamin D deficiency, decreased bone formation and a decreased BMC in patients with liver cirrhosis.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Decreased serum HDL3, cholesterol levels in cirrho...

on New England Journal of Medicin... Jun 25, 1981

Decreased serum osteocalcin levels in phenprocoumo...

on The Journal of Clinical Endocr... May 1988
More articles like this..